Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The market for atopic dermatitis treatment reached about USD 11.43 billion in 2023. The industry is further expected to grow at a CAGR of about 8.6% in the forecast period of 2024-2032. It will reach an approximate value of USD 24.07 billion by the end of 2032, driven by the rising awareness about the importance of treatment among the people.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is expected to hold a significant share of the global atopic dermatitis market. The influencing factors include the growing number of people suffering from skin disorders, rapid climate changes, the thriving population and increasing disposable income. The increasing awareness about the importance of treatment is making people more inclined to follow the procedures and get the cure, which increases the significance of the atopic dermatitis treatment market.
The United States and Canada have well-established and advanced healthcare infrastructures. With the early adoption of novel prescriptions and improved and favourable reimbursement regulations, it is made possible for patients to go for the services provided without facing any burdens. Furthermore, pharmaceutical companies are growing their business relations with research organisations to target the developing region by increasing their investments in R&D to make advancements and focus on launching new products. With the technological advances and the introduction of new procedures in the medical field, the market is likely to grow further in the coming years.
Atopic dermatitis, also known as eczema, is a skin condition where the patient's skin gets red, itchy, dry, and bumpy. It usually develops in early childhood but can occur at any age, and the likelihood of getting dermatitis increases if the person's family has a genetic history of atopic dermatitis.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for atopic dermatitis treatment, by drug class, can be broadly divided into:
The modes of administration in the market are as follows:
By distribution channels, the market for atopic dermatitis treatment can be divided into:
Regional atopic disease treatment markets can be divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Skin problems like allergies and chronic disorders are increasing, and with the rapid climate changes, these disorders will not slow down anytime soon. Growing investments in healthcare can accelerate the market's growth as the dermatology sector has been rising rapidly. Medical Organizations are collaborating with the governments to develop new procedures and policies, equipping the institutes with state-of-the-art technology to support the increasing number of patients and let them avail the treatments easily, which shows promising growth for the market.
The key players are focusing on mergers and collaborations with leading players of foreign regions to build their presence in foreign markets and make product advancements with the collaborative effort. They are creating novel prescriptions and cost-effective treatments for the developing countries and people who are unable to afford to top of the line options. The thriving population of countries like China and India having a massive population shows excellent scope for growth of the atopic dermatitis treatment market.
The report gives a detailed analysis of the following key players in the global atopic dermatitis treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Drug Class |
|
Breakup by Mode of Administration |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the global district heating market attained a value of nearly USD 11.43 billion.
The market is projected to grow at a CAGR of 8.6% between 2024 and 2032.
The market is estimated to witness healthy growth in the forecast period of 2024-2032 to reach USD 24.07 billion by 2032.
The primary industry drivers include the rising dermatology sector, increasing initiatives to spread awareness about the treatment, and the rising competition among the key players.
The collaboration with the government to improvise the policies and procedures of the treatment is a key driver propelling market growth.
The major regions in the industry are North America, Latin America, the Middle East, Africa, Europe, and the Asia Pacific, with North America being the most prominent market region.
In the atopic dermatitis treatment, the drug class can be divided into Corticosteroids, Calcineurin inhibitors, immunosuppressants, Biologic Therapy, PDE-4 inhibitors, antibiotics, antihistamines, and emollients.
The modes of administration can be segmented into topical, oral, and injectable.
The distribution channels of the market include hospital pharmacies, retail pharmacies, online pharmacies, drug stores, and dermatology clinics, among others.
The major players in the industry are Pfizer Inc., Astellas Pharma Inc., AbbVie Inc., Bristol-Myers Squibb Company, and Sanofi SA, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124